Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSE MKTFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
13.30 → 13.14 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for PRK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Total assets grow to at least $12.9 billion | grew total assets to $12.984 billion by Q1 2026 through acquisition. | Intact | total assets fall below $12.0 billion | Total assets: $12.646B FY2026-Q3; GAAP. Published target: >= $12.9 billion. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 26, 202612,646,245,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
PRK is a regional bank with a growth-through-acquisitions angle, rather than a clear turnaround or high-growth story. Its long-term thesis is in a watch state: momentum improved, but management execution is mixed and recent financial performance remains below its industry cohort.
The valuation is stretched, trading at a 1.53 premium versus peers, with a durable premium identified as the main reason. The expectations gap is 0.15, but the evidence does not explain that measure further; fragility is rated low because weak execution is not paired with the full set of expensive, weak, and turbulent conditions.
Near term, the latest update included an earnings beat and company momentum improved, while the miss-risk assessment is quiet despite a history of a deep miss and recent peer misses. Over the multi-year view, loan growth and the First Citizens acquisition support expansion, but integration remains ongoing and the supplied evidence does not confirm systems conversion is complete.
A guidance cut on the next call would be a meaningful negative, while continued strong results and higher guidance from sector bellwethers could support sector momentum. The rate backdrop also matters: the evidence says rate cuts from the current level would weigh on PRK and other financial companies.
Over the next one to three years, the thesis depends on turning acquisition-led growth into sound execution while closing the performance gap with peers. The valuation is stretched, and integration progress and guidance are key evidence to watch. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It maintains a stable dividend, recently raised to $1.10 per share. |
| Intact |
| dividend per share falls below $1.05 |
Dividend per share: $1.10 per share FY2026-Q2; GAAP. Published target: >= $1.10 per share. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 7, 20261.1 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
EPS at least $11.11 in 2026 | A primary condition in Park National Corp.'s published investment case. The stated target is >= $11.11. | Intact | EPS guidance falls below $11.11 for 2026 | Diluted EPS: $3.13 per share FY2026-Q3; GAAP. Published target: >= $11.11. Target period ends 2026-12-31; this observation covers 2026-Q3. Oct 26, 20263.13 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating income at least $51 million | A supporting condition in Park National Corp.'s published investment case. The stated target is >= $51 million. | Intact | operating income falls below $50 million | Operating income: $70.801M FY2026-Q3; GAAP. Published target: >= $51 million. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 26, 202670,801,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$12.71 → $13.14 · observed estimates
$0.70B → $0.71B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $12.71 | $696,066,670 | 4 / 3 |
| 2026-07-25 | $12.71 | $696,066,670 | 4 / 3 |
| 2026-07-26 | $12.71 | $696,066,670 | 4 / 3 |
| 2026-07-27 | $12.71 | $696,076,500 | 3 / 2 |
| 2026-07-28 | $12.71 | $696,066,670 | 4 / 3 |
| 2026-07-29 | $12.71 | $696,066,670 | 4 / 3 |
| 2026-07-30 | $12.71 | $696,066,670 | 4 / 3 |
| 2026-07-31 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-01 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-02 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-03 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-04 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-05 | $13.23 | $709,412,330 | 4 / 3 |
| 2026-08-06 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-07 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-08 | $13.23 | $709,412,330 | 4 / 3 |
| 2026-08-09 | $13.23 | $709,412,330 | 4 / 3 |
| 2026-08-10 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-12 | $13.23 | $709,412,330 | 4 / 3 |
| 2026-08-13 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-14 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-15 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-16 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-17 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-18 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-19 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-20 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-21 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-22 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-23 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-24 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-25 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-26 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-27 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-28 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-29 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-30 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-08-31 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-01 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-02 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-03 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-04 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-05 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-06 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-07 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-08 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-09 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-10 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-11 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-12 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-13 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-14 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-15 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-16 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-17 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-18 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-19 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-20 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-21 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-22 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-23 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-24 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-25 | $13.23 | $709,425,500 | 3 / 2 |
| 2026-09-26 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-09-27 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-09-28 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-09-29 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-09-30 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-01 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-02 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-03 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-04 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-05 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-06 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-07 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-08 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-09 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-10 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-11 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-12 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-13 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-14 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-15 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-16 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-17 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-18 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-19 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-20 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-21 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-22 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-23 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-24 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-25 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-26 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-27 | $13.30 | $712,169,125 | 4 / 3 |
| 2026-10-28 | $13.13 | $713,016,375 | 4 / 3 |
| 2026-10-29 | $13.14 | $714,256,500 | 4 / 3 |
| 2026-10-30 | $13.14 | $714,256,500 | 4 / 3 |
| 2026-10-31 | $13.14 | $714,256,500 | 4 / 3 |
| 2026-11-01 | $13.14 | $714,256,500 | 4 / 3 |
| 2026-11-02 | $13.14 | $714,256,500 | 4 / 3 |
| 2026-11-03 | $13.14 | $714,256,500 | 4 / 3 |
| 2026-11-04 | $13.14 | $714,256,500 | 4 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.